Porton Pharma Solutions Ltd
SZSE:300363
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
13.56
29.41
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Porton Pharma Solutions Ltd stock under the Base Case scenario is 18.69 CNY. Compared to the current market price of 25.86 CNY, Porton Pharma Solutions Ltd is Overvalued by 28%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Porton Pharma Solutions Ltd.
Fundamental Analysis
Profitability Score
Profitability Due Diligence
Score
Solvency Score
Solvency Due Diligence
Score
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Porton Pharma Solutions Ltd
Balance Sheet Decomposition
Porton Pharma Solutions Ltd
Porton Pharma Solutions Ltd
Free Cash Flow Analysis
Porton Pharma Solutions Ltd
| CNY | |
| Free Cash Flow | CNY |
Earnings Waterfall
Porton Pharma Solutions Ltd
Wall St
Price Targets
Price Targets Summary
Porton Pharma Solutions Ltd
According to Wall Street analysts, the average 1-year price target for Porton Pharma Solutions Ltd is 30.6 CNY with a low forecast of 30.3 CNY and a high forecast of 31.5 CNY.
Dividends
Current shareholder yield for Porton Pharma Solutions Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Porton Pharma Solutions Ltd stock under the Base Case scenario is 18.69 CNY.
Compared to the current market price of 25.86 CNY, Porton Pharma Solutions Ltd is Overvalued by 28%.